03/09/2026
Researchers recently mapped out fifteen naturally occurring compounds found in a certain well-known forest mushroom genus and evaluated how each one behaves inside the body.
The goal was to see which compounds could realistically have an effect. To do that, scientists looked at several key factors:
* whether the compounds could survive digestion
* whether they could absorb through the gut
* and whether they could cross the bloodâbrain barrier
That last step is crucial. A compound might interact strongly with receptors in a lab setting, but if it cannot reach the brain, its real neurological impact remains mostly theoretical.
Out of the fifteen compounds examined, eight passed all the tests.
These included psilocin (a metabolite produced after digestion), norpsilocin, 4-hydroxytryptamine, 4-hydroxy-N,N,N-trimethyltryptamine, phenylethylamine, and three naturally occurring β-carbolines: harmane, harmol, and harmaline.
Across the analysis, these compounds showed:
* strong predicted gastrointestinal absorption
* the ability to reach the brain
* properties commonly associated with drug-like molecules in pharmacology
The models also suggested relatively low predicted toxicity, with estimated oral LDâ
â values generally above 700 mg/kg.
The takeaway: these mushrooms contain a complex biochemical profile, and researchers are still uncovering how these naturally occurring compounds might interact within biological systems.